Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ALT
#2659
Altimmune, Inc. Common Stock
4.3
1
-4.01%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-4.01%
Aylık değişim
-27.81%
6 aylık değişim
+14.02%
Yıllık değişim
-31.04%
Önceki kapanış
4.4
9
Open
4.3
1
Bid
Ask
Low
4.3
1
High
4.3
1
Hacim
103
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ALT
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
71.12 M
77.01 M
81.11 M
88.26 M
104.25 M
—
Valuation ratios
Enterprise value
405.23 M
518.34 M
356.43 M
158.45 M
331.8 M
1.37 B
Price to earnings ratio
-3.94
-5.38
-3.97
-3.28
-3.52
-16.15
Price to sales ratio
6 772.94
25.6 K
18.01 K
14.29 K
14.44 K
72.34 K
Price to cash flow ratio
-5.21
-6.41
-4.47
-3.49
-4.33
-18.7
Price to book ratio
0.61
4.14
0.65
0.51
0.48
5.79
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.17
0.12
0.12
0.09
0.49
Return on equity %
0.17
0.19
0.14
0.14
0.1
0.57
Return on invested capital %
1 038.07
—
937.74
1 091.39
1 172.35
—
Gross margin %
100
100
100
100
100
400
Operating margin %
495.34 K
497.32 K
436.3 K
458.44 K
417.18 K
1.81 M
EBITDA margin %
—
—
—
—
—
—
Net margin %
456.9 K
463.6 K
391.5 K
442.92 K
380.28 K
1.68 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
16.87
13.11
15.85
20.44
17.18
66.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.08
0.07
—
Long term debt to total equity ratio
—
—
—
0.09
0.08
—
Per share metrics
Operating cash flow per share
0.38
0.26
0.22
0.24
0.13
0.85
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.96
1.86
1.98
2.25
2.36
8.45
Net current asset value per share
2.05
1.93
2.06
2.31
2.42
8.72
Tangible book value per share
1.88
1.74
1.88
1.98
2.08
7.68
Working capital per share
1.93
1.79
1.93
2.2
2.28
8.19
Book value per share
1.88
1.74
1.88
1.98
2.08
7.68
Haberler
AIM Smarter, Christopher Young’ı ticari direktör olarak atadı
AIM Smarter appoints Christopher Young as chief commercial officer
Obesity stocks slump on Novo’s underwhelming 2026 sales forecast
Obesity stocks slump on Novo's underwhelming 2026 sales forecast
Novo Nordisk hisseleri zayıf 2026 satış görünümü nedeniyle düşüşte
Novo Nordisk hisseleri zayıf 2026 satış beklentisiyle sert düştü
Novo Nordisk shares plunge on weak 2026 sales outlook
Altimmune 75 milyon dolarlık kayıtlı doğrudan teklifini tamamladı
Altimmune closes $75 million registered direct offering
Altimmune: Why Breakthrough Status Isn't A 'Buy' Signal Just Yet (NASDAQ:ALT)
Altimmune (ALT) Shares Slide On $75 Million Stock Offering - Altimmune (NASDAQ:ALT)
Altimmune hisseleri 75 milyon dolarlık doğrudan satış duyurusunun ardından düştü